In medical terms, CIP stands for critical illness polyneuropathy, a nerve disorder that develops in patients who are seriously ill and spending extended time in an intensive care unit (ICU). It affects 30% to 70% of critically ill patients and is one of the most common neurological complications of prolonged ICU stays. While CIP can also occasionally appear as shorthand for other terms like congenital insensitivity to pain, critical illness polyneuropathy is by far its most recognized medical use.
What Critical Illness Polyneuropathy Is
CIP is a type of nerve damage that develops during a severe illness, not before it. The condition targets the long nerve fibers (axons) that carry signals between your brain and your muscles and skin, particularly in the arms and legs. It tends to affect the parts of the body farthest from the spine first, meaning weakness and numbness typically start in the hands and feet before moving inward.
Both motor nerves (which control movement) and sensory nerves (which carry signals about touch, temperature, and pain) are involved. This means CIP causes not just weakness but also reduced sensation. In many cases, the diaphragm and other breathing muscles are also affected, which is why CIP frequently shows up as an unexplained difficulty getting a patient off a ventilator. When doctors have ruled out heart and lung problems but a patient still can’t breathe independently, CIP is one of the first things they investigate.
How Common It Is
The numbers depend on how you look for it. Among patients on mechanical ventilation for four to seven days, clinical exams pick up CIP or a related muscle condition (called critical illness myopathy, or CIM) in 25% to 33% of cases. Electrical nerve testing catches it more often, identifying it in up to 58% of those same patients. For patients in the ICU for at least a week, the rate climbs higher: 49% to 77% will develop some form of ICU-acquired weakness from nerve or muscle damage.
Causes and Risk Factors
CIP develops as a secondary complication of critical illness itself. Sepsis is the single biggest risk factor. When the body mounts an overwhelming inflammatory response to infection, the flood of inflammatory molecules damages the tiny blood vessels that supply nerves, starving them of oxygen and nutrients. Prolonged organ failure, extended time on a ventilator, high blood sugar, and the use of certain sedatives or paralyzing drugs during ICU care all raise the risk further.
The nerve damage in CIP is axonal, meaning the core of the nerve fiber degenerates rather than just losing its insulating sheath. This distinction matters because axonal damage is slower to repair than damage to the outer coating alone.
Symptoms and How It’s Identified
The hallmark signs of CIP include widespread weakness that’s worse in the hands and feet than near the trunk, early loss of reflexes, and difficulty weaning off a ventilator despite adequate lung and heart function. Muscle bulk is usually preserved or only mildly reduced, at least initially, which helps distinguish CIP from conditions where muscles waste rapidly.
Diagnosis relies heavily on nerve conduction studies and electromyography (EMG). In CIP, these tests show a characteristic pattern: the electrical signals traveling along nerves are weaker than normal in amplitude, but they still travel at normal speed. That speed-versus-strength distinction is the electrical fingerprint of axonal damage rather than damage to the nerve’s insulating layer. The EMG also picks up spontaneous electrical activity in muscles at rest, a sign that the nerves controlling those muscles have been injured.
CIP vs. Critical Illness Myopathy
CIP is often discussed alongside critical illness myopathy (CIM), and the two conditions frequently overlap. CIM damages the muscles themselves rather than the nerves, though the end result, profound weakness during or after an ICU stay, looks very similar at the bedside. Distinguishing between them matters because CIM tends to carry a better prognosis. Patients with pure muscle involvement generally recover faster, often within six months, while those with nerve damage from CIP or a combination of CIP and CIM tend to have a slower, more drawn-out recovery.
Recovery and Long-Term Outlook
The prognosis for CIP is better than many people expect. Roughly 70% of survivors with ICU-acquired weakness achieve a full recovery. That number improves with time: among patients followed for two to eight years after their ICU stay, nearly 89% eventually regained full function.
Recovery timelines vary. Patients with CIM alone often recover within six months. Those with CIP, whether on its own or combined with CIM, typically face a more gradual process stretching six to twelve months or longer. More than half of patients with nerve involvement still have some lingering deficits at the one-year mark, though continued improvement beyond that point is common. Rehabilitation, including physical and occupational therapy, is the primary tool for supporting recovery since no specific drug treatment exists for the nerve damage itself.
CIP as Congenital Insensitivity to Pain
In genetics and pain medicine, CIP sometimes refers to congenital insensitivity to pain, an extremely rare inherited condition in which a person cannot feel physical pain from birth. This is an entirely different disorder from critical illness polyneuropathy.
Congenital insensitivity to pain is caused by mutations in a gene called SCN9A, which provides the blueprint for a sodium channel found on pain-sensing nerve cells. When the gene is nonfunctional, these sodium channels never open, and pain signals from an injury site cannot travel to the brain. People with this condition can break a bone or touch a hot surface without feeling anything. The same type of sodium channel is also found in smell-sensing nerve cells, so most people with the condition also have a complete loss of the sense of smell.
While it might sound like an advantage, congenital insensitivity to pain is dangerous. Pain exists as a warning system, and without it, injuries go unnoticed and untreated, leading to repeated fractures, burns, joint damage, and infections that accumulate over a lifetime.